Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI, June 11, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced...
Zoomlion's Humanoid Robot Z01 Shines at KOMATEK 2026, Showcasing Advances in Embodied AI and Industrial Robotics
ISTANBUL, June 10, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") attracted widespread attention at KOMATEK 2026 in Istanbul with the appearance of its humanoid robot Z01. Alongside more than 40 high-end...
Behind CISCE with Jason: Inside a hardcore automobile manufacturer and its supplier network
BEIJING, June 8, 2026 /PRNewswire/ -- This is a report from China.org.cn Video Link: https://youtu.be/9NLo7nKtGo8 The China International Supply Chain Expo, or CISCE, showcases not only finished products but also the networks of companies behind...
Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS
CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical...
Reach Showcases Full-Stack Product Portfolio for AI Vehicle Intelligent Evolution at Auto China 2026
BEIJING, April 30, 2026 /PRNewswire/ -- At Auto China 2026, Reach officially unveiled its full-stack product portfolio designed to accelerate the intelligent evolution of AI vehicles. Industry leaders and experts, along with executives and...
LG ELECTRONICS PRESENTS HYBRID EMERGENCY CALL SOLUTION AT 5GAA IN SWEDEN
Enhancing Driver Safety, Hybrid eCall Enables Seamless Emergency Communication Across 2G to 5G Networks in Compliance with Europe's 2027 NG eCall Requirements News Summary LG Electronics showcased its Hybrid eCall solution at the 37th 5GAA Meeting...
Caliway's Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204's Demonstrated Efficacy and Safety Gain Further Academic Recognition
Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the Aesthetic Surgery Journal (ASJ), a leading academic journal in aesthetic medicine and plastic...
Hankook Strengthens Motorsport Presence at the 2026 Hi-Tec Oils Bathurst 6 Hour
Hankook proves its top-tier technological leadership by serving as the official tyre supplier to the 'Bathurst 6 Hour' for the second consecutive year Ventus TD delivered consistent grip, stability and durability across six hours of racing...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection,...
RoboSense Driving Ecosystem Deployment with Global Partners at NVIDIA GTC 2026
SHENZHEN, China, March 17, 2026 /PRNewswire/ -- RoboSense (HKEX: 2498), an AI-driven robotics technology company, today demonstrated the extensive commercial footprint of its collaboration with NVIDIA at GTC 2026. As a core partner across the NVIDIA...